Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

Similar articles for PubMed (Select 22858112)

1.

[Predictive value of intraepithelial (CD3) T-lymphocyte infiltration in resected colorectal cancer].

Borda F, Martínez-Peñuela JM, Borda A, Muñoz-Navas M, Jiménez J, Carretero C.

Gastroenterol Hepatol. 2012 Oct;35(8):541-50. doi: 10.1016/j.gastrohep.2012.05.003. Epub 2012 Aug 2. Spanish.

PMID:
22858112
2.

Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor.

Allard MA, Bachet JB, Beauchet A, Julie C, Malafosse R, Penna C, Nordlinger B, Emile JF.

Diagn Pathol. 2012 Nov 13;7:156. doi: 10.1186/1746-1596-7-156.

3.

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.

Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB.

BMC Immunol. 2010 Apr 12;11:19. doi: 10.1186/1471-2172-11-19.

4.

The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.

Ling A, Edin S, Wikberg ML, Öberg Å, Palmqvist R.

Br J Cancer. 2014 May 13;110(10):2551-9. doi: 10.1038/bjc.2014.161. Epub 2014 Mar 27.

5.

Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.

Correale P, Rotundo MS, Botta C, Del Vecchio MT, Ginanneschi C, Licchetta A, Conca R, Apollinari S, De Luca F, Tassone P, Tagliaferri P.

Clin Cancer Res. 2012 Feb 1;18(3):850-7. doi: 10.1158/1078-0432.CCR-10-3186. Epub 2011 Dec 5.

6.

Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss.

Clarke B, Tinker AV, Lee CH, Subramanian S, van de Rijn M, Turbin D, Kalloger S, Han G, Ceballos K, Cadungog MG, Huntsman DG, Coukos G, Gilks CB.

Mod Pathol. 2009 Mar;22(3):393-402. doi: 10.1038/modpathol.2008.191. Epub 2008 Dec 5.

7.

Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma.

Al-Maghrabi J, Al-Ahwal M, Buhmeida A, Syrjänen K, Sibyani A, Emam E, Ghanim A, Al-Qahtani M.

J Gastrointest Cancer. 2012 Jun;43(2):279-87. doi: 10.1007/s12029-011-9292-y.

PMID:
21637966
8.

The clinical utility of the local inflammatory response in colorectal cancer.

Richards CH, Roxburgh CS, Powell AG, Foulis AK, Horgan PG, McMillan DC.

Eur J Cancer. 2014 Jan;50(2):309-19. doi: 10.1016/j.ejca.2013.09.008. Epub 2013 Oct 5.

PMID:
24103145
9.

CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A, Mantovani A, Roncalli M, Malesci A.

Lancet Oncol. 2009 Sep;10(9):877-84. doi: 10.1016/S1470-2045(09)70186-X. Epub 2009 Aug 3.

PMID:
19656725
10.

Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.

Buhmeida A, Bendardaf R, Hilska M, Collan Y, Laato M, Syrjänen S, Syrjänen K, Pyrhönen S.

J Gastrointest Cancer. 2009;40(3-4):91-7. doi: 10.1007/s12029-009-9091-x.

PMID:
19921474
11.

PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma.

Buhmeida A, Bendardaf R, Hilska M, Laine J, Collan Y, Laato M, Syrjänen K, Pyrhönen S.

Ann Oncol. 2009 Jul;20(7):1230-5. doi: 10.1093/annonc/mdn783. Epub 2009 Mar 10.

12.

[Variation in the prognostic value of p53 protein in relation to tumoral stage in patients with colorectal adenocarcinoma].

Díez M, Pollán M, Ramos P, Villeta R, Ratia T, Hernández P, Lozano O, Noguerales F, Granell J.

Cir Esp. 2005 Apr;77(4):213-20. Spanish.

13.

The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients.

Milasiene V, Stratilatovas E, Norkiene V.

Medicina (Kaunas). 2007;43(7):548-54.

14.

Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT.

Clin Cancer Res. 2008 Aug 15;14(16):5220-7. doi: 10.1158/1078-0432.CCR-08-0133.

15.

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.

Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, Sargent DJ.

Gastroenterology. 2009 Oct;137(4):1270-9. doi: 10.1053/j.gastro.2009.06.053. Epub 2009 Jul 3.

16.

Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR, Koelle DM, Galloway DA, Leonard JH, Madeleine MM, Argenyi ZB, Disis ML, Becker JC, Cleary MA, Nghiem P.

J Clin Oncol. 2011 Apr 20;29(12):1539-46. doi: 10.1200/JCO.2010.30.6308. Epub 2011 Mar 21.

17.

Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.

Yang B, Su K, Gao J, Rao Z.

Asian Pac J Cancer Prev. 2012;13(3):1049-52.

18.

Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.

Arigami T, Uenosono Y, Ishigami S, Hagihara T, Haraguchi N, Natsugoe S.

World J Surg. 2011 Sep;35(9):2051-7. doi: 10.1007/s00268-011-1186-4.

PMID:
21748517
19.

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M.

J Clin Oncol. 2011 Apr 20;29(12):1547-55. doi: 10.1200/JCO.2010.30.5151. Epub 2011 Mar 21.

20.

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.

Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, Lothe RA.

Gut. 2012 Nov;61(11):1560-7. Epub 2012 Jan 2.

PMID:
22213796
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk